Meningococcal Vaccine | Shim Clinic, Singapore
|
|
Summary
Meningococcal Vaccine | Shim Clinic, Singapore: Meningococcal meningitis vaccine jab/shot/injection, to vaccinate against Neisseria meningitidis / meningococcus, to immunise against meningococcal disease / meningitis / meningococcemia clinic, Singapore. Private and confidential service. Definitions, references, and latest news.
Description
Vaccine types available for vaccination: | Vaccine | Against | Disease | Age | D o s e s | Dose schedule | Price per dose (SG$) | Fluarix™ Influenza vaccine | Influenza virus | Influenza | 6-36m | ½ | 1 yearly | $30/= | | >3y | 1 | Typhim Vi Typhoid vaccine | Salmonella typhi | Typhoid fever | >5y | 1 | 3 yearly | $40/= | Tetavax Tetanus vaccine | Clostridium tetani | Tetanus | adults | 3 | 1-2m interval 3rd @ 6-12m after 2nd | $20/= | | booster | 1 | 10 yearly | Varilrix™ - Chickenpox vaccine - Varicella vaccine - Shingles vaccine - Herpes zoster vaccine | Varicella zoster virus | Chickenpox Herpes zoster | 12m-12y | 1 | | $121/= | | ≥13y | 2 | 6-10w interval | Mencevax® ACWY - Meningococcal vaccine - Meningitis vaccine | Neisseria meningitidis types A, C, W-135 and Y | Meningococcal meningitis | >2y | 1 | | $76/= | Pneumovax® 23 - Pneumococcal polysaccharide vaccine - Pneumococcal vaccine | Streptococcus pneumoniae types 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19F, 19A, 20, 22F, 23F and 33F | Pneumococcal infection | ≥50y | 1 | | $99/= | Prevenar 13® - Pneumococcal conjugate vaccine - Pneumococcal vaccine | Streptococcus pneumoniae types 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F | Pneumococcal infection | 6w-6m | 4 | 1m interval 4th @ 12-15m | $274/= | | 7-11m | 2 | 1m interval | | 12-23m | 2 | 2m interval | | 2-5y | 1 | | ≥50y | 1 | | MMR vaccine | | | ≥12m | 1 | | $70/= | | - Measles vaccine | Measles virus | Measles | | - Mumps vaccine | Mumps virus | Mumps | | - Rubella vaccine | Rubella virus | Rubella | Boostrix® - DPT vaccine - DTP vaccine | | | ≥4y | 1 | <10 yearly | $70/= | | - Diphtheria vaccine | Corynebacterium diphtheriae | Diphtheria | | - Tetanus vaccine | Clostridium tetani | Tetanus | - Pertussis vaccine - Whooping cough vaccine | Bordetella pertussis | Pertussis Whooping cough | Meningococcal vaccine is recommended for persons traveling to sub-Saharan Africa, especially during the dry season (December to June), to other areas of current or recent epidemic activity, and to Mecca at any time. Particularly for the Hajj/Haj and Umrah. If the clinic attendance is just for vaccination alone, no additional consultation fees are charged. STD vaccine / hepatitis vaccine shot/jab/injection to prevent some STDs | Vaccine | Against | Disease | Age | D o s e s | Dose schedule | Price per dose (SG$) | Havrix™ 1440 Adult Hepatitis A vaccine | Hepatitis A virus | Hepatitis A | ≥19y | 2 | m 0 & 6-12 | $90/= | Engerix™-B 20 μg Hepatitis B vaccine | Hepatitis B virus | Hepatitis B | 11-15y | 2 | m 0, & 6 | $50/= | | ≥20y | 3 | m 0, 1, & 6 | | 4 | m 0, 1, 2, & 12 or d 0, 7, 21 & m 12 | | Twinrix® | Hepatitis A virus Hepatitis B virus | Hepatitis A Hepatitis B | 1-15y | 2 | m 0, 6-12 | $120/= | | ≥16y | 3 | m 0, 1, 6 | | 4 | d 0, 7, 21 & m 12 | Gardasil® - HPV vaccine | HPV types 6, 11, 16 and 18 | Genital warts Cervical cancer | 9-26y | 3 | m 0, 2, & 6 or m 0, 1, & 4 | $195/= | Cervarix® - HPV vaccine | HPV types 16 and 18 (31, 33, and 45) | Genital warts Cervical cancer | 10-25y | 3 | m 0, 1, & 6 m 0, 1, & 5 m 0, 2½, 12 | $195/= | V503 - HPV vaccine | HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58 | Genital warts Cervical cancer | | 3 | m 0, 2, & 6 or m 0, 1, & 4 | $???/= |
References
Latest News
New Global Vaccine Strategy Glosses Over Basic Immunization Gaps
Tue, 15 May 2012 14:02:00 +0100 | MSF News
South Sudan 2011 © Avril Benoit/MSF
An MSF staff member vaccinates a child against measles in Abathok.
GENEVA/NEW YORK, 15 MAY 2012—A new, ten-year, multi-billion dollar action plan for global vaccination may fail to deliver if it does not directly address the weaknesses in routine immunization programs. One in five children—nineteen million worldwide—are being missed each year and this challenge must be explicitly addressed, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) said today.
A "Global Vaccines Action Plan" has been designed to implement the "Decade of Vaccines" project and will be considered by health ministers gathering next week in Geneva for the 65th Wor...
Impact of the emergence of non‐vaccine pneumococcal serotypes on the clinical presentation and outcome of adults with invasive pneumococcal pneumonia
Mon, 14 May 2012 04:00:00 +0100 | Clinical Microbiology and Infection
In conclusion, the incidence of IPP in the post‐vaccine period has increased in our setting, it is caused mainly by non‐vaccine serotypes and it is associated with higher rates of septic shock. (Source: Clinical Microbiology and Infection)
A role for glycosylated Serine‐rich repeatproteins in Gram‐positive bacterial pathogenesis
Fri, 11 May 2012 04:15:03 +0100 | Oral Microbiology and Immunology
SummaryBacterial attachment to host surfaces is a pivotal event in the biological and infectious processes of both commensal and pathogenic bacteria, respectively.Serine‐rich Repeat Proteins (SRRPs) are a family of adhesins in Gram‐Positive bacteria that mediate attachment to a variety of host and bacterial surfaces. As such, they contribute towards a wide‐range of diseases including sub‐acute bacterial endocarditis, community‐acquired pneumonia, and meningitis. SRRPs are unique in that they are glycosylated, require a non‐canonical Sec‐translocase for transport, and are largely composed of a domaincontaining hundreds of alternating serine residues. These serine‐rich repeats are thought to extend a unique non‐repeat (NR) domain outward away from the bacterial surface to m...
Ghana: Major Effort to Reduce Child Mortality Not Enough
Thu, 10 May 2012 10:58:14 +0100 | AllAfrica News: Health and Medicine
[IPS]
Accra -
Ghana has taken a major step towards reducing its under-five mortality rate by becoming the first African country to introduce two new vaccines for rotavirus and pneumococcal disease. (Source: AllAfrica News: Health and Medicine)
Major Effort to Reduce Child Mortality Not Enough
Thu, 10 May 2012 10:40:41 +0100 | IPS Inter Press Service - Health
Ghana has taken a major step towards reducing its under-five mortality rate by
becoming the first African country to introduce two new vaccines for rotavirus
and pneumococcal disease. (Source: IPS Inter Press Service - Health)
Broad-spectrum meningitis vaccine shows promise in phase II
Thu, 10 May 2012 00:00:00 +0100 | MedWire News - Infectious Diseases
A new vaccine could prevent the vast majority of meningitis cases, results of an international randomized placebo-controlled phase II trial indicate. (Source: MedWire News - Infectious Diseases)
Pediatric osteoarticular infections caused by Streptococcus pneumoniae before and after the introduction of the heptavalent pneumococcal conjugate vaccine
Wed, 09 May 2012 05:53:06 +0100 | European Journal of Clinical Microbiology and Infectious Diseases
The objective of this study was to investigate the clinical
and laboratory characteristics of pneumococcal OAI before and after the introduction of the heptavalent pneumococcal conjugate
vaccine (PCV7). Data were retrospectively collected from children aged <16 years who were hospitalized for pneumococcal OAI
between 1997 and 2007 in four Parisian teaching hospitals. Forty-three children were included (32 with arthritis and 11 with
osteomyelitis) and the median age of these children was 12.5 months (range 3 months to 14 years). Serotypes were available
for 19/43 strains (44 %) from 1997 onwards and for 12/13 strains (92 %) from 2005 onwards. Seven unvaccinated children were
infected with vaccine serotypes and we observed only one vaccine failure. Af...
Diseases spread as food supplies dwindle
Tue, 08 May 2012 16:41:00 +0100 | MSF News
Food and water are scarce in Chad’s eastern city of Biltine, and some families are down to their last two weeks’ worth of food, says Kodjo Edoh, a physician working for Médecins Sans Frontières (MSF) in Chad. As a result of this food and water scarcity, malnutrition rates amongst children are soaring. Elsewhere in the country, measles and a deadly epidemic of meningitis have broken out.
2012 Chad © Andrea Bussotti/MSFMSF staff examine a young malnutrition patient in Chad’s Yao district.
Even in a ‘good’ year in Chad, many people struggle to get hold of sufficient food during the April to September lean season, and thousands of children become malnourished. But no one is expecting 2012 to be a good year. Last year, the rains did not come, and food prices are on the rise – ...
RCT evaluates immunogenicity of meningococcal serogroup B vaccine in healthy adolescents
Tue, 08 May 2012 04:00:00 +0100 | NeLM - News
Source: Lancet Infectious Diseases
Area: News
The findings of a study evaluating the immunogenicity of an investigational meningococcal serogroup B vaccine in healthy volunteers have been published early online in the Lancet Infectious Diseases.
The authors note that asymptomatic carriage of Neisseria meningitidis is common, with a peak incidence in the late teenage years. In some cases the bacterium causes invasive meningococcal disease, which is associated with a case fatality rate of 5% to 14%, even with appropriate antibiotic therapy. Survivors often have permanent serious sequelae, such as neurological disability, limb loss, and hearing loss.
Neisseria meningitidis serogroup B is a major cause of invasive meningococcal disease. Unlike disease caused ...
|